Woodline Partners’s Compugen CGEN Stock Holding History

Woodline Partners’s Portfolio CGEN Stock Details CGEN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-80,556	Closed	-$208K	–	572
2024 Q1	$208K	Buy	+80,556	New	+$188K	﹤0.01%	515

Other funds holding CGEN

SCM

Silverarc Capital Management Boston, Massachusetts $980M AUM 470.8% 1-Year Est. Return

TFCM

Taylor Frigon Capital Management Scottsdale, Arizona $176M AUM 24.25% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

AIM

ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

RSCM

Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

SFM

Sphera Funds Management Tel Aviv, Israel $630M AUM 108.65% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

DCM

DAFNA Capital Management Los Angeles, California $440M AUM 109.12% 1-Year Est. Return

Woodline Partners's CGEN Position: Q2 2024 in Review

Woodline Partners sold out of Compugen (CGEN) in Q2 2024, closing a stake of 80,556 shares — an estimated $208K sold.

Woodline Partners first reported a position in CGEN in Q1 2024 and held it in 1 quarter. The position peaked at $208K in Q1 2024. 66 funds tracked by Wall St. Rank hold CGEN as of Q2 2024.

Woodline Partners reported no remaining Compugen position as of Q2 2024 after selling out during the quarter.
Woodline Partners sold 80,556 Compugen shares in Q2 2024, an estimated $208K.
Woodline Partners first reported a position in Compugen in Q1 2024 and held it in 1 quarter.
Woodline Partners's Compugen position peaked at $208K in Q1 2024.
66 funds tracked by Wall St. Rank held Compugen as of Q2 2024.

Based on Woodline Partners's 13F filing for Q2 2024, filed 14 Aug 2024.